Welcome to LookChem.com Sign In|Join Free
  • or
4-(2-(4-broMo-2-fluorophenoxy)ethyl)Morpholine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

714237-09-9

Post Buying Request

714237-09-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

714237-09-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 714237-09-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,4,2,3 and 7 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 714237-09:
(8*7)+(7*1)+(6*4)+(5*2)+(4*3)+(3*7)+(2*0)+(1*9)=139
139 % 10 = 9
So 714237-09-9 is a valid CAS Registry Number.

714237-09-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[2-(4-bromo-2-fluoro-phenoxy)-ethyl]-morpholine

1.2 Other means of identification

Product number -
Other names 4-[2-(4-bromo-2-fluorophenoxy)ethyl]morpholine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:714237-09-9 SDS

714237-09-9Relevant academic research and scientific papers

THIAZOLYL-DIHYDRO-INDAZOLES

-

Page/Page column 35, (2009/10/22)

The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a

NOBEL COMPOUNDS HAVING SELECTIVE INHIBITING EFFECT AT GSK3

-

Page 30, (2008/06/13)

The present invention relates to new compounds, a process for their preparation and new intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy, such as pr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 714237-09-9